Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 69 entries
Sorted by: Best Match Show Resources per page
Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review.

Therapeutic advances in medical oncology

Chibaudel B, Tournigand C, Bonnetain F, Richa H, Benetkiewicz M, André T, de Gramont A.
PMID: 26673925
Ther Adv Med Oncol. 2015 May;7(3):153-69. doi: 10.1177/1758834015572343.

Systemic therapy is the standard care for patients with unresectable advanced colorectal cancer (CRC), but salvage surgery of metastatic disease should be considered in the case of adequate tumor shrinkage. Several drugs and combinations are now available for use...

Cite
Chibaudel B, Tournigand C, Bonnetain F, et al. Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review. Ther Adv Med Oncol. 2015;7(3):153-69doi: 10.1177/1758834015572343.
Chibaudel, B., Tournigand, C., Bonnetain, F., Richa, H., Benetkiewicz, M., André, T., & de Gramont, A. (2015). Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review. Therapeutic advances in medical oncology, 7(3), 153-69. https://doi.org/10.1177/1758834015572343
Chibaudel, Benoist, et al. "Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review." Therapeutic advances in medical oncology vol. 7,3 (2015): 153-69. doi: https://doi.org/10.1177/1758834015572343
Chibaudel B, Tournigand C, Bonnetain F, Richa H, Benetkiewicz M, André T, de Gramont A. Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review. Ther Adv Med Oncol. 2015 May;7(3):153-69. doi: 10.1177/1758834015572343. PMID: 26673925; PMCID: PMC4406914.
Copy Download .nbib Format: NLM
[Not Available].

Revue d'histoire de la pharmacie

Bonnemain H.
PMID: 11628730
Rev Hist Pharm (Paris). 1982 Mar;29(252):39-48.

No abstract available.

Cite
Bonnemain H. La Faculté de Pharmacie de Paris depuis cent ans Avenue de de l'Observatoire. [Not Available]. Rev Hist Pharm (Paris). 1982;29(252):39-48
Bonnemain, H. (1982). La Faculté de Pharmacie de Paris depuis cent ans Avenue de de l'Observatoire. [Not Available]. Revue d'histoire de la pharmacie, 29(252), 39-48.
Bonnemain, H. "La Faculté de Pharmacie de Paris depuis cent ans Avenue de de l'Observatoire." [Not Available]. Revue d'histoire de la pharmacie vol. 29,252 (1982): 39-48.
Bonnemain H. La Faculté de Pharmacie de Paris depuis cent ans Avenue de de l'Observatoire. [Not Available]. Rev Hist Pharm (Paris). 1982 Mar;29(252):39-48. French. PMID: 11628730.
Copy Download .nbib Format: NLM
Involvement of Protons as a Substrate for the Sucrose Carrier during Phloem Loading in Vicia faba Leaves.

Plant physiology

Delrot S, Bonnemain JL.
PMID: 16661714
Plant Physiol. 1981 Mar;67(3):560-4. doi: 10.1104/pp.67.3.560.

The effect of pH on uptake of exogenous sucrose by broadbean (Vicia faba L.) leaf discs without the lower epidermis has been investigated at various sucrose concentrations. The concentration dependence of sucrose uptake showed a biphasic saturation response. At...

Cite
Delrot S, Bonnemain JL. Involvement of Protons as a Substrate for the Sucrose Carrier during Phloem Loading in Vicia faba Leaves. Plant Physiol. 1981;67(3):560-4doi: 10.1104/pp.67.3.560.
Delrot, S., & Bonnemain, J. L. (1981). Involvement of Protons as a Substrate for the Sucrose Carrier during Phloem Loading in Vicia faba Leaves. Plant physiology, 67(3), 560-4. https://doi.org/10.1104/pp.67.3.560
Delrot, S, and Bonnemain, J L. "Involvement of Protons as a Substrate for the Sucrose Carrier during Phloem Loading in Vicia faba Leaves." Plant physiology vol. 67,3 (1981): 560-4. doi: https://doi.org/10.1104/pp.67.3.560
Delrot S, Bonnemain JL. Involvement of Protons as a Substrate for the Sucrose Carrier during Phloem Loading in Vicia faba Leaves. Plant Physiol. 1981 Mar;67(3):560-4. doi: 10.1104/pp.67.3.560. PMID: 16661714; PMCID: PMC425725.
Copy Download .nbib Format: NLM
Inhibition of Loading of C Assimilates by p-Chloromercuribenzenesulfonic Acid : Localization of the Apoplastic Pathway in Vicia faba.

Plant physiology

Bourquin S, Bonnemain JL, Delrot S.
PMID: 16667271
Plant Physiol. 1990 Jan;92(1):97-102. doi: 10.1104/pp.92.1.97.

The apoplast of mature leaves excised from broadbean (Vicia faba L.) plants was infiltrated with 2 millimolar p-chloromercuribenzenesulfonic acid (PCMBS) via the transpiration stream, and the ability of the tissues to take up sugars was tested. An infiltration time...

Cite
Bourquin S, Bonnemain JL, Delrot S. Inhibition of Loading of C Assimilates by p-Chloromercuribenzenesulfonic Acid : Localization of the Apoplastic Pathway in Vicia faba. Plant Physiol. 1990;92(1):97-102doi: 10.1104/pp.92.1.97.
Bourquin, S., Bonnemain, J. L., & Delrot, S. (1990). Inhibition of Loading of C Assimilates by p-Chloromercuribenzenesulfonic Acid : Localization of the Apoplastic Pathway in Vicia faba. Plant physiology, 92(1), 97-102. https://doi.org/10.1104/pp.92.1.97
Bourquin, S, et al. "Inhibition of Loading of C Assimilates by p-Chloromercuribenzenesulfonic Acid : Localization of the Apoplastic Pathway in Vicia faba." Plant physiology vol. 92,1 (1990): 97-102. doi: https://doi.org/10.1104/pp.92.1.97
Bourquin S, Bonnemain JL, Delrot S. Inhibition of Loading of C Assimilates by p-Chloromercuribenzenesulfonic Acid : Localization of the Apoplastic Pathway in Vicia faba. Plant Physiol. 1990 Jan;92(1):97-102. doi: 10.1104/pp.92.1.97. PMID: 16667271; PMCID: PMC1062253.
Copy Download .nbib Format: NLM
Donor stabilized borylnitrene: a highly reactive BN analogue of vinylidene.

Journal of the American Chemical Society

Bettinger HF, Bornemann H.
PMID: 16925431
J Am Chem Soc. 2006 Aug 30;128(34):11128-34. doi: 10.1021/ja061346y.

A donor atom stabilized borylnitrene, 2-nitreno-1,3,2-benzodioxaborole 4c, is characterized by matrix isolation IR, UV, and ESR spectroscopy as well as multiconfiguration SCF and CI computations. UV irradiation (lambda = 254 nm) of the corresponding azide 6c, isolated in solid...

Cite
Bettinger HF, Bornemann H. Donor stabilized borylnitrene: a highly reactive BN analogue of vinylidene. J Am Chem Soc. 2006;128(34):11128-34doi: 10.1021/ja061346y.
Bettinger, H. F., & Bornemann, H. (2006). Donor stabilized borylnitrene: a highly reactive BN analogue of vinylidene. Journal of the American Chemical Society, 128(34), 11128-34. https://doi.org/10.1021/ja061346y
Bettinger, Holger F, and Bornemann, Holger. "Donor stabilized borylnitrene: a highly reactive BN analogue of vinylidene." Journal of the American Chemical Society vol. 128,34 (2006): 11128-34. doi: https://doi.org/10.1021/ja061346y
Bettinger HF, Bornemann H. Donor stabilized borylnitrene: a highly reactive BN analogue of vinylidene. J Am Chem Soc. 2006 Aug 30;128(34):11128-34. doi: 10.1021/ja061346y. PMID: 16925431.
Copy Download .nbib Format: NLM
Energy profiles for ketene cyclizations. Interconversion of 1,3-oxazin-6-ones, mesoionic 1,3-oxazinium olates and acylketenes, imidoylketenes, oxoketenimines, and cyclization products.

The Journal of organic chemistry

Bornemann H, Wentrup C.
PMID: 16018679
J Org Chem. 2005 Jul 22;70(15):5862-8. doi: 10.1021/jo050429e.

The energy surface connecting oxazinium olates 9, several possible conformers of ketenes 10 and 11, and the final cyclization products 12, 13 and 14, as well as the isomeric 1,3-oxazine-6-ones 15, ring opening of the latter to N-acylimidoylketenes 16,...

Cite
Bornemann H, Wentrup C. Energy profiles for ketene cyclizations. Interconversion of 1,3-oxazin-6-ones, mesoionic 1,3-oxazinium olates and acylketenes, imidoylketenes, oxoketenimines, and cyclization products. J Org Chem. 2005;70(15):5862-8doi: 10.1021/jo050429e.
Bornemann, H., & Wentrup, C. (2005). Energy profiles for ketene cyclizations. Interconversion of 1,3-oxazin-6-ones, mesoionic 1,3-oxazinium olates and acylketenes, imidoylketenes, oxoketenimines, and cyclization products. The Journal of organic chemistry, 70(15), 5862-8. https://doi.org/10.1021/jo050429e
Bornemann, Holger, and Wentrup, Curt. "Energy profiles for ketene cyclizations. Interconversion of 1,3-oxazin-6-ones, mesoionic 1,3-oxazinium olates and acylketenes, imidoylketenes, oxoketenimines, and cyclization products." The Journal of organic chemistry vol. 70,15 (2005): 5862-8. doi: https://doi.org/10.1021/jo050429e
Bornemann H, Wentrup C. Energy profiles for ketene cyclizations. Interconversion of 1,3-oxazin-6-ones, mesoionic 1,3-oxazinium olates and acylketenes, imidoylketenes, oxoketenimines, and cyclization products. J Org Chem. 2005 Jul 22;70(15):5862-8. doi: 10.1021/jo050429e. PMID: 16018679.
Copy Download .nbib Format: NLM
Metal-free conversion of methane and cycloalkanes to amines and amides by employing a borylnitrene.

Angewandte Chemie (International ed. in English)

Bettinger HF, Filthaus M, Bornemann H, Oppel IM.
PMID: 18481829
Angew Chem Int Ed Engl. 2008;47(25):4744-7. doi: 10.1002/anie.200705936.

No abstract available.

Cite
Bettinger HF, Filthaus M, Bornemann H, et al. Metal-free conversion of methane and cycloalkanes to amines and amides by employing a borylnitrene. Angew Chem Int Ed Engl. 2008;47(25):4744-7doi: 10.1002/anie.200705936.
Bettinger, H. F., Filthaus, M., Bornemann, H., & Oppel, I. M. (2008). Metal-free conversion of methane and cycloalkanes to amines and amides by employing a borylnitrene. Angewandte Chemie (International ed. in English), 47(25), 4744-7. https://doi.org/10.1002/anie.200705936
Bettinger, Holger F, et al. "Metal-free conversion of methane and cycloalkanes to amines and amides by employing a borylnitrene." Angewandte Chemie (International ed. in English) vol. 47,25 (2008): 4744-7. doi: https://doi.org/10.1002/anie.200705936
Bettinger HF, Filthaus M, Bornemann H, Oppel IM. Metal-free conversion of methane and cycloalkanes to amines and amides by employing a borylnitrene. Angew Chem Int Ed Engl. 2008;47(25):4744-7. doi: 10.1002/anie.200705936. PMID: 18481829.
Copy Download .nbib Format: NLM
Source-to-sink transport of sugar and regulation by environmental factors.

Frontiers in plant science

Lemoine R, La Camera S, Atanassova R, Dédaldéchamp F, Allario T, Pourtau N, Bonnemain JL, Laloi M, Coutos-Thévenot P, Maurousset L, Faucher M, Girousse C, Lemonnier P, Parrilla J, Durand M.
PMID: 23898339
Front Plant Sci. 2013 Jul 24;4:272. doi: 10.3389/fpls.2013.00272. eCollection 2013.

Source-to-sink transport of sugar is one of the major determinants of plant growth and relies on the efficient and controlled distribution of sucrose (and some other sugars such as raffinose and polyols) across plant organs through the phloem. However,...

Cite
Lemoine R, La Camera S, Atanassova R, et al. Source-to-sink transport of sugar and regulation by environmental factors. Front Plant Sci. 2013;4:272doi: 10.3389/fpls.2013.00272.
Lemoine, R., La Camera, S., Atanassova, R., Dédaldéchamp, F., Allario, T., Pourtau, N., Bonnemain, J. L., Laloi, M., Coutos-Thévenot, P., Maurousset, L., Faucher, M., Girousse, C., Lemonnier, P., Parrilla, J., & Durand, M. (2013). Source-to-sink transport of sugar and regulation by environmental factors. Frontiers in plant science, 4272. https://doi.org/10.3389/fpls.2013.00272
Lemoine, Remi, et al. "Source-to-sink transport of sugar and regulation by environmental factors." Frontiers in plant science vol. 4 (2013): 272. doi: https://doi.org/10.3389/fpls.2013.00272
Lemoine R, La Camera S, Atanassova R, Dédaldéchamp F, Allario T, Pourtau N, Bonnemain JL, Laloi M, Coutos-Thévenot P, Maurousset L, Faucher M, Girousse C, Lemonnier P, Parrilla J, Durand M. Source-to-sink transport of sugar and regulation by environmental factors. Front Plant Sci. 2013 Jul 24;4:272. doi: 10.3389/fpls.2013.00272. eCollection 2013. PMID: 23898339; PMCID: PMC3721551.
Copy Download .nbib Format: NLM
[Diagnosis and management of hyperammonemia].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie

Bonnemains C, Feillet F.
PMID: 19541112
Arch Pediatr. 2009 Jun;16(6):634-6. doi: 10.1016/S0929-693X(09)74094-1.

No abstract available.

Cite
Bonnemains C, Feillet F. Conduite à tenir devant une hyperammoniémie. [Diagnosis and management of hyperammonemia]. Arch Pediatr. 2009;16(6):634-6doi: 10.1016/S0929-693X(09)74094-1.
Bonnemains, C., & Feillet, F. (2009). Conduite à tenir devant une hyperammoniémie. [Diagnosis and management of hyperammonemia]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 16(6), 634-6. https://doi.org/10.1016/S0929-693X(09)74094-1
Bonnemains, C, and Feillet, F. "Conduite à tenir devant une hyperammoniémie." [Diagnosis and management of hyperammonemia]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie vol. 16,6 (2009): 634-6. doi: https://doi.org/10.1016/S0929-693X(09)74094-1
Bonnemains C, Feillet F. Conduite à tenir devant une hyperammoniémie. [Diagnosis and management of hyperammonemia]. Arch Pediatr. 2009 Jun;16(6):634-6. doi: 10.1016/S0929-693X(09)74094-1. French. PMID: 19541112.
Copy Download .nbib Format: NLM
Publisher Correction: A PRDX1 mutant allele causes a MMACHC secondary epimutation in cblC patients.

Nature communications

Guéant JL, Chéry C, Oussalah A, Nadaf J, Coelho D, Josse T, Flayac J, Robert A, Koscinski I, Gastin I, Filhine-Tresarrieu P, Pupavac M, Brebner A, Watkins D, Pastinen T, Montpetit A, Hariri F, Tregouët D, Raby BA, Chung WK, Morange PE, Froese DS, Baumgartner MR, Benoist JF, Ficicioglu C, Marchand V, Motorin Y, Bonnemains C, Feillet F, Majewski J, Rosenblatt DS.
PMID: 29396438
Nat Commun. 2018 Feb 02;9(1):554. doi: 10.1038/s41467-018-03054-w.

The original version of this Article contained an error in the title, which was incorrectly given as 'APRDX1 mutant allele causes a MMACHC secondary epimutation in cblC patients'. This has now been corrected in both the PDF and HTML...

Cite
Guéant JL, Chéry C, Oussalah A, et al. Publisher Correction: A PRDX1 mutant allele causes a MMACHC secondary epimutation in cblC patients. Nat Commun. 2018;9(1):554doi: 10.1038/s41467-018-03054-w.
Guéant, J. L., Chéry, C., Oussalah, A., Nadaf, J., Coelho, D., Josse, T., Flayac, J., Robert, A., Koscinski, I., Gastin, I., Filhine-Tresarrieu, P., Pupavac, M., Brebner, A., Watkins, D., Pastinen, T., Montpetit, A., Hariri, F., Tregouët, D., Raby, B. A., Chung, W. K., Morange, P. E., Froese, D. S., Baumgartner, M. R., Benoist, J. F., Ficicioglu, C., Marchand, V., Motorin, Y., Bonnemains, C., Feillet, F., Majewski, J., & Rosenblatt, D. S. (2018). Publisher Correction: A PRDX1 mutant allele causes a MMACHC secondary epimutation in cblC patients. Nature communications, 9(1), 554. https://doi.org/10.1038/s41467-018-03054-w
Guéant, Jean-Louis, et al. "Publisher Correction: A PRDX1 mutant allele causes a MMACHC secondary epimutation in cblC patients." Nature communications vol. 9,1 (2018): 554. doi: https://doi.org/10.1038/s41467-018-03054-w
Guéant JL, Chéry C, Oussalah A, Nadaf J, Coelho D, Josse T, Flayac J, Robert A, Koscinski I, Gastin I, Filhine-Tresarrieu P, Pupavac M, Brebner A, Watkins D, Pastinen T, Montpetit A, Hariri F, Tregouët D, Raby BA, Chung WK, Morange PE, Froese DS, Baumgartner MR, Benoist JF, Ficicioglu C, Marchand V, Motorin Y, Bonnemains C, Feillet F, Majewski J, Rosenblatt DS. Publisher Correction: A PRDX1 mutant allele causes a MMACHC secondary epimutation in cblC patients. Nat Commun. 2018 Feb 02;9(1):554. doi: 10.1038/s41467-018-03054-w. PMID: 29396438; PMCID: PMC5797229.
Copy Download .nbib Format: NLM
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards.

The Lancet. Oncology

Bottomley A, Pe M, Sloan J, Basch E, Bonnetain F, Calvert M, Campbell A, Cleeland C, Cocks K, Collette L, Dueck AC, Devlin N, Flechtner HH, Gotay C, Greimel E, Griebsch I, Groenvold M, Hamel JF, King M, Kluetz PG, Koller M, Malone DC, Martinelli F, Mitchell SA, Moinpour CM, Musoro J, O'Connor D, Oliver K, Piault-Louis E, Piccart M, Pimentel FL, Quinten C, Reijneveld JC, Schürmann C, Smith AW, Soltys KM, Taphoorn MJB, Velikova G, Coens C.
PMID: 27769798
Lancet Oncol. 2016 Nov;17(11):e510-e514. doi: 10.1016/S1470-2045(16)30510-1. Epub 2016 Oct 18.

Measures of health-related quality of life (HRQOL) and other patient-reported outcomes generate important data in cancer randomised trials to assist in assessing the risks and benefits of cancer therapies and fostering patient-centred cancer care. However, the various ways these...

Cite
Bottomley A, Pe M, Sloan J, et al. Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards. Lancet Oncol. 2016;17(11):e510-e514doi: 10.1016/S1470-2045(16)30510-1.
Bottomley, A., Pe, M., Sloan, J., Basch, E., Bonnetain, F., Calvert, M., Campbell, A., Cleeland, C., Cocks, K., Collette, L., Dueck, A. C., Devlin, N., Flechtner, H. H., Gotay, C., Greimel, E., Griebsch, I., Groenvold, M., Hamel, J. F., King, M., Kluetz, P. G., Koller, M., Malone, D. C., Martinelli, F., Mitchell, S. A., Moinpour, C. M., Musoro, J., O'Connor, D., Oliver, K., Piault-Louis, E., Piccart, M., Pimentel, F. L., Quinten, C., Reijneveld, J. C., Schürmann, C., Smith, A. W., Soltys, K. M., Taphoorn, M. J. B., Velikova, G., Coens, C. (2016). Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards. The Lancet. Oncology, 17(11), e510-e514. https://doi.org/10.1016/S1470-2045(16)30510-1
Bottomley, Andrew, et al. "Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards." The Lancet. Oncology vol. 17,11 (2016): e510-e514. doi: https://doi.org/10.1016/S1470-2045(16)30510-1
Bottomley A, Pe M, Sloan J, Basch E, Bonnetain F, Calvert M, Campbell A, Cleeland C, Cocks K, Collette L, Dueck AC, Devlin N, Flechtner HH, Gotay C, Greimel E, Griebsch I, Groenvold M, Hamel JF, King M, Kluetz PG, Koller M, Malone DC, Martinelli F, Mitchell SA, Moinpour CM, Musoro J, O'Connor D, Oliver K, Piault-Louis E, Piccart M, Pimentel FL, Quinten C, Reijneveld JC, Schürmann C, Smith AW, Soltys KM, Taphoorn MJB, Velikova G, Coens C. Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards. Lancet Oncol. 2016 Nov;17(11):e510-e514. doi: 10.1016/S1470-2045(16)30510-1. Epub 2016 Oct 18. PMID: 27769798.
Copy Download .nbib Format: NLM
Determinants of Quality of Life in Children with Inborn Errors of Metabolism Receiving a Restricted Diet.

The Journal of pediatrics

Ouattara A, Resseguier N, Cano A, De Lonlay P, Arnoux JB, Brassier A, Schiff M, Pichard S, Fabre A, Hoebeke C, Guffon N, Fouilhoux A, Broué P, Touati G, Dobbelaere D, Mention K, Labarthe F, Tardieu M, De Parscau L, Feillet F, Bonnemains C, Kuster A, Labrune P, Barth M, Damaj L, Lamireau D, Berbis J, Auquier P, Chabrol B.
PMID: 34788681
J Pediatr. 2021 Nov 14; doi: 10.1016/j.jpeds.2021.11.021. Epub 2021 Nov 14.

OBJECTIVE: To investigate the determinants of quality of life (QoL) in children with inborn errors of metabolism with restricted diet (IEMRDs) using a single theory-based multidimensional model.STUDY DESIGN: In this multicenter cross-sectional study, data from children with IEMRDs (except...

Cite
Ouattara A, Resseguier N, Cano A, et al. Determinants of Quality of Life in Children with Inborn Errors of Metabolism Receiving a Restricted Diet. J Pediatr. 2021;doi: 10.1016/j.jpeds.2021.11.021.
Ouattara, A., Resseguier, N., Cano, A., De Lonlay, P., Arnoux, J. B., Brassier, A., Schiff, M., Pichard, S., Fabre, A., Hoebeke, C., Guffon, N., Fouilhoux, A., Broué, P., Touati, G., Dobbelaere, D., Mention, K., Labarthe, F., Tardieu, M., De Parscau, L., Feillet, F., Bonnemains, C., Kuster, A., Labrune, P., Barth, M., Damaj, L., Lamireau, D., Berbis, J., Auquier, P., & Chabrol, B. (2021). Determinants of Quality of Life in Children with Inborn Errors of Metabolism Receiving a Restricted Diet. The Journal of pediatrics, . https://doi.org/10.1016/j.jpeds.2021.11.021
Ouattara, Abdoulaye, et al. "Determinants of Quality of Life in Children with Inborn Errors of Metabolism Receiving a Restricted Diet." The Journal of pediatrics vol. (2021). doi: https://doi.org/10.1016/j.jpeds.2021.11.021
Ouattara A, Resseguier N, Cano A, De Lonlay P, Arnoux JB, Brassier A, Schiff M, Pichard S, Fabre A, Hoebeke C, Guffon N, Fouilhoux A, Broué P, Touati G, Dobbelaere D, Mention K, Labarthe F, Tardieu M, De Parscau L, Feillet F, Bonnemains C, Kuster A, Labrune P, Barth M, Damaj L, Lamireau D, Berbis J, Auquier P, Chabrol B. Determinants of Quality of Life in Children with Inborn Errors of Metabolism Receiving a Restricted Diet. J Pediatr. 2021 Nov 14; doi: 10.1016/j.jpeds.2021.11.021. Epub 2021 Nov 14. PMID: 34788681.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 69 entries